- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03603067
The Study of Psychological Status in Monophthalmic Patients With Ocular Surgery
July 26, 2018 updated by: Aier School of Ophthalmology, Central South University
A Prospective, Non-randomized, Controlled Study: To Evaluate the Psychological Status of Monophthalmic Patients Before and After Ocular Surgery
This study is designed to evaluate the change of psychological status before and after surgery in monophthalmic patients who receive the ocular surgery in eye with better vision.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Monophthalmos means the best corrected visual acuity (BCVA) of the worse eye is less than 0.05 or the central visual field (CFOV) is less than 5°.
The ocular surgery of the better eye in monophthalmic patients is of high risk.
On the one hand the surgical failure will result in the patient falling into permanent darkness.
On the other hand the monophthalmic patient may have the same disease in both two eyes such as high axial myopia, uveitis and glaucoma, which will increase the surgical risk.
There is still no consensus on whether it is necessary to take risks to perform this kind of operation.
In this study we will evaluate the change of psychological status before and after surgery in monophthalmic patients who receive the ocular surgery in eye with better vision.
The necessity of the ocular surgery in monophthalmic patients will be evaluated from the point of social psychology.
Study Type
Observational
Enrollment (Anticipated)
60
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Zhuyun A Qian
- Phone Number: +8613817109809 +8613817109809
- Email: qianzhuyun552@126.com
Study Contact Backup
- Name: Wensheng A Li
- Phone Number: +8618650424985 +8618650424985
- Email: drlws@qq.com
Study Locations
-
-
Shanghai
-
Shanghai, Shanghai, China, 200000
- Recruiting
- Shanghai Aier Eye Hospital
-
Contact:
- Zhuyun Qian
- Phone Number: +8613817109809
- Email: qianzhuyun552@126.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients hospitalized in Shanghai Aier Eye Hospital and are intended to receive ocular surgery in one of two eyes.
Description
Inclusion Criteria:
- Intention to receive ocular surgery in one of two eyes.
- Free from prior mental disorders.
- Without general disease and can tolerate the operation.
- Communication without difficulty.
Exclusion Criteria:
- With prior mental disorders.
- Can not tolerate the operation.
- Communication with difficulty.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
monophthalmic group
The BCVA of the worse eye is less than 0.05 or CFOV is less than 5°.
The better eye need to receive ocular surgery.
|
Different ocular surgeries (including vitreoretinal surgery, cataract surgery, anti-glaucoma surgery etc) will be performed in one eye of the patient.
In monophthalmic patient group the surgery will be performed in eye with better visual acuity.
|
Normal group
The BCVA of the worse eye is more than 0.3 and CFOV is more than 10°.
One of two eyes need to receive ocular surgery.
|
Different ocular surgeries (including vitreoretinal surgery, cataract surgery, anti-glaucoma surgery etc) will be performed in one eye of the patient.
In monophthalmic patient group the surgery will be performed in eye with better visual acuity.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Level of anxiety
Time Frame: Change from Baseline HAMA score at 6 months.
|
Hamilton anxiety scale(HAMA)will be filled in by each patient and the final score will be recorded.
The total score ranges from 0-56.
A score less than 7 means no symptom of anxiety.
A score between 7 to 14 means possible anxiety.
A score between 14-21 means mild anxiety.
A score between 21-29 means moderate anxiety.
A score more than 29 means severe symptom of anxiety.
|
Change from Baseline HAMA score at 6 months.
|
Level of depression
Time Frame: Change from Baseline HAMD score at 6 months.
|
Hamilton depression scale (HAMD) will be filled in by each patient and the final score will be recorded.
The total score ranges from 0-56.
A score less than 8 means no symptom of depression.
A score between 8 to 35 means mild or moderate depression.
A score more than 35 means severe symptom of depression.
|
Change from Baseline HAMD score at 6 months.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Level of social support
Time Frame: Change from Baseline SSRS score at 6 months.
|
Social support rating scale (SSRS) will be filled in by each patient and the final score will be recorded.
|
Change from Baseline SSRS score at 6 months.
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Visual function
Time Frame: One day before surgery and one day, one months, three months and six months after surgery.
|
BCVA and intraocular pressure (IOP) wlll be recorded.
|
One day before surgery and one day, one months, three months and six months after surgery.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Wensheng Li, Shanghai Aier Eye Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
January 1, 2018
Primary Completion (ANTICIPATED)
June 30, 2019
Study Completion (ANTICIPATED)
December 31, 2019
Study Registration Dates
First Submitted
July 7, 2018
First Submitted That Met QC Criteria
July 26, 2018
First Posted (ACTUAL)
July 27, 2018
Study Record Updates
Last Update Posted (ACTUAL)
July 27, 2018
Last Update Submitted That Met QC Criteria
July 26, 2018
Last Verified
June 1, 2018
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- SHIRB2018018
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
IPD Plan Description
Individual participant data will be partly shared in published papers.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Surgery
-
3MRecruitingAbdominal Surgery | Orthopedic Surgery | Vascular Surgery | Cardiovascular SurgeryUnited States
-
Vanderbilt UniversityCompletedHand Surgery | Wrist Surgery | Forearm Surgery | Elbow SurgeryUnited States
-
Nantes University HospitalCompletedGynecological Surgery | Plastic Surgery | ENT SurgeryFrance
-
Edwards LifesciencesCompletedAbdominal Surgery | Pelvic Surgery | Non-Cardiac/ Non-Thoracic Surgery | Major Peripheral Vascular SurgeryUnited States
-
Maquet Cardiopulmonary GmbHNAMSARecruitingCardiac Surgery | Cardiopulmonary Bypass | Thoracic Surgery | Vascular SurgerySpain
-
Baylor Research InstituteChiesi USA, Inc.RecruitingSurgery | Cardiac Surgery | Surgery--Complications | Percutaneous Coronary InterventionUnited States
-
Vanderbilt UniversityEdwards LifesciencesCompletedCardiac Surgery | Thoracic Surgery | Heart Surgery | Heart Transplant
-
Surgify Medical OyCompletedSurgery | Spine SurgeryFinland
-
Cairo UniversityBatterjee Medical College; Taif UniversityCompletedSurgery | Bariatric SurgeryEgypt, Saudi Arabia
-
Poudre Valley Health SystemTerminatedSurgery | Surgery--ComplicationsUnited States
Clinical Trials on Ocular surgery
-
The First Affiliated Hospital with Nanjing Medical...UnknownGlaucoma | Diabetic Retinopathy | Pterygium | Proliferative VitreoretinopathyChina
-
Prim. Prof. Dr. Oliver Findl, MBARecruiting
-
Western Sussex Hospitals NHS TrustRayner Intraocular Lenses LtdUnknownCataract | AstigmatismUnited Kingdom
-
Insel Gruppe AG, University Hospital BernStiftung OPOS; Fondation BertarelliRecruiting
-
Alcon ResearchCompletedDry Eye DiseaseAustralia
-
First Affiliated Hospital of Harbin Medical UniversityUnknown
-
First Affiliated Hospital of Harbin Medical UniversityUnknown
-
First Affiliated Hospital of Harbin Medical UniversityUnknown
-
Brighton and Sussex University Hospitals NHS TrustCompletedAge Related Macular Degeneration | Cataract Senile | Epiretinal Membrane | Vitreomacular Traction | Macula HoleUnited Kingdom
-
Mersin Training and Research HospitalCompleted